Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressorsBLAGOSKLONNY, Mikhail V.Oncogene (Basingstoke). 2001, Vol 20, Num 3, pp 395-398, issn 0950-9232Article

Nuclear exclusion of p53 in a subset of tumors requires MDM2 functionWENGE LU; POCHAMPALLY, R; LIHONG CHEN et al.Oncogene (Basingstoke). 2000, Vol 19, Num 2, pp 232-240, issn 0950-9232Article

Interactions between p53 and MDM2 in a mammalian cell cycle cehckpoint pathwayCHAW-YUAN CHEN; OLINER, J. D; QIMIN ZHAN et al.Proceedings of the National Academy of Sciences of the United States of America. 1994, Vol 91, Num 7, pp 2684-2688, issn 0027-8424Conference Paper

MDM2 : life without p53DAUJAT, Sylvain; NEEL, Henry; PIETTE, Jacques et al.Trends in genetics (Regular ed.). 2001, Vol 17, Num 8, pp 459-464, issn 0168-9525Article

A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients : an indication for an increased cancer susceptibility?TAUBERT, Helge; KAPPLER, Matthias; MEYE, Axel et al.Mutation research. 2000, Vol 456, Num 1-2, pp 39-44, issn 0027-5107Article

MDM2-dependent ubiquitination of nuclear and cytoplasmic P53ZHONG KANG YU; GEYER, Rory K; MAKI, Carl G et al.Oncogene (Basingstoke). 2000, Vol 19, Num 51, pp 5892-5897, issn 0950-9232Article

Analysis of the degradation function of Mdm2KUBBUTAT, M. H. G; LUDWIG, R. L; LEVINE, A. J et al.Cell growth and differentiation. 1999, Vol 10, Num 2, pp 87-92, issn 1044-9523Article

A 60 kd MDM2 isoform is produced by caspase cleavage in non-apoptotic tumor cellsPOCHAMPALLY, R; FODERA, B; LIHONG CHEN et al.Oncogene (Basingstoke). 1998, Vol 17, Num 20, pp 2629-2636, issn 0950-9232Article

p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 bindingMIDGLEY, C. A; LANE, D. P.Oncogene (Basingstoke). 1997, Vol 15, Num 10, pp 1179-1189, issn 0950-9232Article

Mdm2 overexpression and p14^ARF inactivation are two mutually exclusive events in primary human lung tumorsEYMIN, Béatrice; GAZZERI, Sylvie; BRAMBILLA, Christian et al.Oncogene (Basingstoke). 2002, Vol 21, Num 17, pp 2750-2761, issn 0950-9232Article

Overproduction of MDM2 in vivo disrupts S phase independent of E2F1REINKE, V; BORTNER, D. M; AMELSE, L. L et al.Cell growth and differentiation. 1999, Vol 10, Num 3, pp 147-154, issn 1044-9523Article

p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53WASYLYK, C; SALVI, R; ARGENTINI, M et al.Oncogene (Basingstoke). 1999, Vol 18, Num 11, pp 1921-1934, issn 0950-9232Article

Control of p53 ubiquitination and nuclear export by MDM2 and ARF1YANPING ZHANG; YUE XIONG.Cell growth and differentiation. 2001, Vol 12, Num 4, pp 175-186, issn 1044-9523Article

RB18A regulates p53-dependent apoptosisFRADE, Raymond; BALBO, Michelle; BAREL, Monique et al.Oncogene (Basingstoke). 2002, Vol 21, Num 6, pp 861-866, issn 0950-9232Article

Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular sizeDAZARD, J.-E; PIETTE, J; BASSET-SEGUIN, N et al.Oncogene (Basingstoke). 2000, Vol 19, Num 33, pp 3693-3705, issn 0950-9232Article

The loss of mdm2 induces p53 mediated apoptosisDE ROZIERES, S; MAYA, R; OREN, M et al.Oncogene (Basingstoke). 2000, Vol 19, Num 13, pp 1691-1697, issn 0950-9232Article

The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2BLAYDES, J. P; WYNFORD-THOMAS, D.Oncogene (Basingstoke). 1998, Vol 16, Num 25, pp 3317-3322, issn 0950-9232Article

mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cellsBULL, E. K; CHAKRABARTY, S; BRODSKY, I et al.Oncogene (Basingstoke). 1998, Vol 16, Num 17, pp 2249-2257, issn 0950-9232Article

The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylationGUERRA, B; GÖTZ, C; WAGNER, P et al.Oncogene (Basingstoke). 1997, Vol 14, Num 22, pp 2683-2688, issn 0950-9232Article

MDM2-related responses in 3T3-L1 adipocytes exposed to cooling and subsequent rewarmingOHSAKA, Yasuhito; NISHINO, Hoyoku.Cryobiology (Print). 2010, Vol 61, Num 3, pp 308-316, issn 0011-2240, 9 p.Article

Activation of p53 by roscovitine-mediated suppression of MDM2 expressionWENGE LU; LIHONG CHEN; YANHUA PENG et al.Oncogene (Basingstoke). 2001, Vol 20, Num 25, pp 3206-3216, issn 0950-9232Article

Absence of mutations in the functional domains of the human MDM2 oncogene in non-small cell lung carcinomasMARIATOS, George; GORGOULIS, Vassilis G; KOTSINAS, Athanassios et al.Mutation research. 2000, Vol 456, Num 1-2, pp 59-63, issn 0027-5107Article

Inactivation of the p53-homologue p73 by the mdm2-oncoproteinDOBBELSTEIN, M; WIENZEK, S; KÖNIG, C et al.Oncogene (Basingstoke). 1999, Vol 18, Num 12, pp 2101-2106, issn 0950-9232Article

Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder. CommentaryYURAKH, Andriy O; RAMOS, David; LOPEZ-BELTRAN, Antonio et al.European urology. 2006, Vol 50, Num 3, pp 506-515, issn 0302-2838, 10 p.Article

Mdm2 inhibition of p53 induces E2F1 transactivation via p21WUNDERLICH, Mark; BERBERICH, Steven J.Oncogene (Basingstoke). 2002, Vol 21, Num 28, pp 4414-4421, issn 0950-9232Article